Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Psychological and Social Factors Are a Strong Predictor of Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Independent of Disease Risk and Morbidity Score

Melhem Solh, MD, Dawn Speckhart, PhD, Xu Zhang, PhD, Asad Bashey, MD PhD, Scott R. Solomon, MD, Lawrence E Morris, MD, H. Kent Holland, MD

Blood (2019) 134 (Supplement_1): 3493.

https://doi.org/10.1182/blood-2019-131639

Published: 2019

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Bachar Samra, MD, Hagop M. Kantarjian, MD, Koji Sasaki, MD, Marina Y Konopleva, MD PhD, Rita Khouri, Susan M. O'Brien, MD, Alessandra Ferrajoli, MD, Cesar Nunez, MD, Tapan M. Kadia, MD, Elias Jabbour, MD

Blood (2019) 134 (Supplement_1): 3819.

https://doi.org/10.1182/blood-2019-127499

Published: 2019

Journal Articles

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Mary Mansour Riwes, DO, Alexander Schmidt, Thomas Braun, John M. Magenau, MD, Attaphol Pawarode, Brian Parkin, Sarah Anand, MD, Monalisa Ghosh, John Maciejewski, Darren King, Muneesh Tewari, Sung W. Choi, Gregory A. Yanik, Kristi Maccready, Thomas Schmidt, Pavan Reddy

Blood (2019) 134 (Supplement_1): 3276.

https://doi.org/10.1182/blood-2019-131216

Published: 2019

Journal Articles

Oncolytics Virus Replication Using Pelareorep (Reolysin) and Carfilzomib in Relapsed Myeloma Patients Increases PD-L1 Expression with Clinical Responses

Craig C Hofmeister, MDMPH, Douglas W. Sborov, MD MS, Domenico Viola, Ada Dona, Gerald J Nuovo, PhD, Don M. Benson, Jr., MD PhD, Sagar Lonial, MD, Jonathan L Kaufman, MD, Ajay K Nooka, MD MPH, Leonard Heffner, MD, Madhav V Dhodapkar, MD, Flavia Pichiorri, PhD

Blood (2018) 132 (Supplement 1): 2655.

https://doi.org/10.1182/blood-2018-99-113500

Published: 2018

Journal Articles

KLF1 Acts As a Pioneer Transcription Factor to Open Chromatin and Facilitate Recruitment of GATA1

Kevin R. Gillinder, PhD, Graham Magor, BSc, Charles Bell, BSc, Melissa D. Ilsley, BSc PhD, Stephen Huang, BSc, Andrew Perkins, MBBS, PhD, FRCPA, FRACP

Blood (2018) 132 (Supplement 1): 501.

https://doi.org/10.1182/blood-2018-99-119608

Published: 2018

Journal Articles

Role of mTORC1 and mTORC2 during Chronic Lymphocytic Leukaemia (CLL) Initiation and Progression

Natasha Malik, BSc, Karen Dunn, Owen Sansom, Prof, Alison M Michie, BSc, PhD

Blood (2018) 132 (Supplement 1): 3123.

https://doi.org/10.1182/blood-2018-99-116614

Published: 2018

Journal Articles

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Blood (2017) 130 (Supplement 1): 4257.

https://doi.org/10.1182/blood.V130.Suppl_1.4257.4257

Published: 2017

Journal Articles

Clinical Spectrum of Autoimmune Lymphoproliferative Syndrome Associated with Caspase10 Mutations (ALPS-CASP10)

V. Koneti Rao, MD, Susan Price, Morgan Similuk, Julie Niemela, Joshua D Milner, MD, Sergio Rosenzweig, MD

Blood (2016) 128 (22): 1335.

https://doi.org/10.1182/blood.V128.22.1335.1335

Published: 2016

Journal Articles

Measurable Amount of Active Thrombin Is Bound to Circulating D-Dimers. Is There Any Impact on Diagnosis and Pathophysiology of Thrombosis?

Jan E. Dyr, prof., PhD, MSc., DSc., Jana Stikarova, PhD, MSc., Jiri Suttnar, PhD, MSc., Katerina Kuzelova, PhD, Pavel Sacha, PhD, MSc., Ondrej Kucerka, MD, Jan Louzil, MD, Jaroslav Cermak, MD PhD, Petr Soukup, MD, Peter Salaj, MD, Martin Hajsl, MD, Martin Maly, MD PhD, Roman Kotlin, PhD, MSc.

Blood (2016) 128 (22): 2570.

https://doi.org/10.1182/blood.V128.22.2570.2570

Published: 2016

Journal Articles

Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood . 1975;46(2): 219-234 .

Blood (2016) 128 (17): 2109.

https://doi.org/10.1182/blood-2016-08-737650

Published: 2016

Journal Articles

Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood . 1962;19(3): 267-295 .

Blood (2016) 127 (21): 2505.

https://doi.org/10.1182/blood-2016-02-702365

Published: 2016

Journal Articles

Reissmann KR. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood . 1950;5(4): 372-380 .

Blood (2016) 127 (5): 519.

https://doi.org/10.1182/blood-2015-12-686386

Published: 2016

Journal Articles

The ATP-Competitive mTOR Inhibitor AZD8055 Reduces Cell Proliferation and Tumour Load in Chronic Lymphocytic Leukaemia

Emilio Cosimo, Bsc, PhD, Anuradha Tarafdar, PhD, Ailsa Holroyd, MD, Karen Dunn, BSc hons, Mark Catherwood, PhD, Alison M. Michie, PhD BSc

Blood (2015) 126 (23): 5287.

https://doi.org/10.1182/blood.V126.23.5287.5287

Published: 2015

Journal Articles

Subversion of Pkca and Pkcbii Upregulation Play an Essential Role in Chronic Lymphocytic Leukaemia Development, Inducing Constitutive B Cell Receptor-Mediated Signals

Anuradha Tarafdar, PhD, Ashfia Fatima Khan, M Pharm, Emilio Cosimo, Bsc, PhD, Hothri A. Moka, BSc hons, Karen Dunn, BSc hons, Alison M. Michie, PhD BSc

Blood (2015) 126 (23): 488.

https://doi.org/10.1182/blood.V126.23.488.488

Published: 2015

Journal Articles

Venous Thromboembolism Following L-Asparaginase Treatment in Hematologic Malignancies in Korea

Ji Hyun Lee, MD PhD, Ho-Young Yhim, MD PhD, Soo-Mee Bang, MD PhD

Blood (2015) 126 (23): 4679.

https://doi.org/10.1182/blood.V126.23.4679.4679

Published: 2015

Journal Articles

Mechanisms of Antileukemic Activity of the Multikinase Inhibitors Dasatinib and Ponatinib in Acute Lymphoblastic Leukemia (ALL) Harboring the E2A-PBX1 Fusion Gene

Tamara Tesanovic, Susanne Badura, Thomas Oellerich, Claudia Doering, Martin Ruthardt, MD, Oliver G. Ottmann, MD

Blood (2014) 124 (21): 3595.

https://doi.org/10.1182/blood.V124.21.3595.3595

Published: 2014

Journal Articles

Hicks LK, Bering H, Carson KR, et al. The ASH Choosing Wisely ® campaign: five hematologic tests and treatments to question. Blood . 2013;122(24): 3879-3883 .

Blood (2014) 123 (21): 3364.

https://doi.org/10.1182/blood-2014-04-570556

Published: 2014

Journal Articles

The Incidence, Risk Factors, and Prognosis of Recurrent Venous Thromboembolism (VTE) in Patients with Advanced Solid Cancers Receiving Anticoagulation Therapy After the Diagnosis of Index Vte; A Korean Venous Thromboembolism Registry Study.

Ho-Young Yhim, MD, Moon Ju Jang, Won-Il Choi, Yong Cheol Lee, Jeong-Ok Lee, Keun-Wook Lee, Soo-Mee Bang, MD, PhD, Sung Hyun Kim, MD, PhD, Yeo-Kyeoung Kim, Hye Jung Chang, MD, Jae-Yong Kwak, Chang-Yeol Yim

Blood (2012) 120 (21): 2247.

https://doi.org/10.1182/blood.V120.21.2247.2247

Published: 2012

Journal Articles

A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside

Sean P. McDermott, Kolja Eppert, Faiyaz Notta, Methvin Isaac, Alessandro Datti, Rima Al-awar, Jeff Wrana, Mark D. Minden, John E. Dick

Blood (2012) 119 (5): 1200–1207.

https://doi.org/10.1182/blood-2011-01-330019

Published: 2012

Includes: Supplemental data

Journal Articles

Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers

Blood (2011) 118 (21): 1866.

https://doi.org/10.1182/blood.V118.21.1866.1866

Published: 2011

NARROW

Psychological and Social Factors Are a Strong Predictor of Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Independent of Disease Risk and Morbidity Score

Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Oncolytics Virus Replication Using Pelareorep (Reolysin) and Carfilzomib in Relapsed Myeloma Patients Increases PD-L1 Expression with Clinical Responses

KLF1 Acts As a Pioneer Transcription Factor to Open Chromatin and Facilitate Recruitment of GATA1

Role of mTORC1 and mTORC2 during Chronic Lymphocytic Leukaemia (CLL) Initiation and Progression

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Clinical Spectrum of Autoimmune Lymphoproliferative Syndrome Associated with Caspase10 Mutations (ALPS-CASP10)

Measurable Amount of Active Thrombin Is Bound to Circulating D-Dimers. Is There Any Impact on Diagnosis and Pathophysiology of Thrombosis?

Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood . 1975;46(2): 219-234 .

Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood . 1962;19(3): 267-295 .

Reissmann KR. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood . 1950;5(4): 372-380 .

The ATP-Competitive mTOR Inhibitor AZD8055 Reduces Cell Proliferation and Tumour Load in Chronic Lymphocytic Leukaemia

Subversion of Pkca and Pkcbii Upregulation Play an Essential Role in Chronic Lymphocytic Leukaemia Development, Inducing Constitutive B Cell Receptor-Mediated Signals

Venous Thromboembolism Following L-Asparaginase Treatment in Hematologic Malignancies in Korea

Mechanisms of Antileukemic Activity of the Multikinase Inhibitors Dasatinib and Ponatinib in Acute Lymphoblastic Leukemia (ALL) Harboring the E2A-PBX1 Fusion Gene

Hicks LK, Bering H, Carson KR, et al. The ASH Choosing Wisely ® campaign: five hematologic tests and treatments to question. Blood . 2013;122(24): 3879-3883 .

The Incidence, Risk Factors, and Prognosis of Recurrent Venous Thromboembolism (VTE) in Patients with Advanced Solid Cancers Receiving Anticoagulation Therapy After the Diagnosis of Index Vte; A Korean Venous Thromboembolism Registry Study.

A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside

Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only